SCHEMBL3754702

SCHEMBL3754702

Nc1ccccc1NC(=O)c1ccc(OCCNC(=O)c2cc3cccc(CN4CCOCC4)c3o2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 12/20 0.51
HDAC2 Q92769 3/20 0.47
RXFP1 Q9HBX9 1/20 0.46
HDAC3 O15379 3/20 0.45
HDAC4 P56524 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
BCL3 P20749 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662772 0.94 HDAC1 (0.49) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3664968 0.93 HDAC1 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL444983 0.88 RXFP1 (0.52) HDAC1HDAC2RXFP1HDAC3HDAC4
SCHEMBL3661190 0.86 HDAC2 (0.53) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3663554 0.85 SMN1; SMN2 (0.54) HDAC1HDAC2HDAC3HDAC6HPGD
SCHEMBL3664230 0.84 HDAC2 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3665583 0.84 HDAC2 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3657262 0.84 SMN1; SMN2 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL3661035 0.84 HDAC1 (0.51) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL4254715 0.83 RXFP1 (0.49) HDAC1RXFP1HPGDTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100292320-A1 BENZOFURAN ANILIDE HISTONE DEACETYLASE INHIBITORS GILEAD COLORADO, INC. (US) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292320-A1 BENZOFURAN ANILIDE HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC7, HDAC5 HDAC1 1/4885HDAC2 4/4885RXFP1 4410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.